177Lu-PSMA-0057
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 177Lu-PSMA-0057, covering 2025-12-30 to 2025-12-30. Get the full timeline:
Most recent: Clinical Trial Update: 68Ga-PSMA-0057 and 177Lu-PSMA-0057 in Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer [Phase 1, Phase 2]